Published in Medical Letter on the CDC and FDA, January 14th, 2007
The legislation will amend the federal Food, Drug and Cosmetic Act to require the reporting of serious adverse events for both over the counter (OTC) drugs and dietary supplements to the U.S. Food and Drug Administration (FDA). It now goes to President Bush for signature.
The bipartisan legislation was introduced in the Senate in June of this year by Sens. Orrin Hatch (R-Utah), Tom Harkin (D-Iowa) and Richard Durbin (D- Ill.) and includes several provisions that were instrumental in earning...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.